Zhao Cuiping, Wang Qingjie, Temple Sally
Neural Stem Cell Institute, 1 Discovery Drive, Rensselaer, NY 12144, USA.
Neural Stem Cell Institute, 1 Discovery Drive, Rensselaer, NY 12144, USA
Development. 2017 Apr 15;144(8):1368-1381. doi: 10.1242/dev.133108.
Retinal degenerative diseases are the leading causes of blindness worldwide. Replacing lost retinal cells via stem cell-based therapies is an exciting, rapidly advancing area of translational research that has already entered the clinic. Here, we review the status of these clinical efforts for several significant retinal diseases, describe the challenges involved and discuss how basic developmental studies have contributed to and are needed to advance clinical goals.
视网膜退行性疾病是全球失明的主要原因。通过基于干细胞的疗法替代丢失的视网膜细胞是一个令人兴奋且发展迅速的转化研究领域,该领域已进入临床阶段。在此,我们综述了针对几种重要视网膜疾病的这些临床研究进展,描述了其中涉及的挑战,并讨论了基础发育研究如何推动了临床目标以及为实现临床目标还需要哪些基础发育研究。